Genenta Science SPA
NASDAQ:GNTA
Genenta Science SPA
Operating Income
Genenta Science SPA
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Genenta Science SPA
NASDAQ:GNTA
|
Operating Income
-€11.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Philogen SpA
MIL:PHIL
|
Operating Income
-€8.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ulisse Biomed Spa
MIL:UBM
|
Operating Income
-€1.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genenta Science SPA's Operating Income?
Operating Income
-11.7m
EUR
Based on the financial report for Dec 31, 2023, Genenta Science SPA's Operating Income amounts to -11.7m EUR.
What is Genenta Science SPA's Operating Income growth rate?
Operating Income CAGR 3Y
-28%
Over the last year, the Operating Income growth was -6%. The average annual Operating Income growth rates for Genenta Science SPA have been -28% over the past three years .